Filing Details

Accession Number:
0000905148-25-000985
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-20 18:47:50
Reporting Period:
2025-03-18
Filing Date:
2025-03-20
Accepted Time:
2025-03-20 18:47:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1287098 Maxcyte Inc. MXCT Services-Commercial Physical & Biological Research (8731) 522210438
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2012430 I. David Sandoval C/O Maxcyte, Inc.
9713 Key West Avenue, Suite 400
Rockville MD 20850
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-03-18 353 $3.18 64,219 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units ("RSUs"). Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $3.14 to $3.215, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.